Document is current
Any future updates will be listed below
-
Authors
Traboulsi, Cindy
Ayoub, Fares
Silfen, Alexa
Rodriguez, Tina G.
Rubin, David T. https://orcid.org/0000-0001-5647-1723
- License Information
-
More Information
Article History
Received: 16 March 2022
Accepted: 23 May 2022
First Online: 13 June 2022
Declarations
:
: DTR has received grant support from from Takeda; and has served as a consultant for Abbvie, Altrubio, Allergan Inc., Arena Pharmaceuticals, Aslan Pharmaceuticals, Athos Therapeutics, Bellatrix Pharmaceuticals, Boehringer Ingelheim Ltd., Bristol-Myers Squibb, Celgene Corp/Syneos, Connect BioPharma, GalenPharma/Atlantica, Genentech/Roche, Glycominds, InDex Pharmaceuticals, Ironwood Pharmaceuticals, Iterative Scopes, Janssen Pharmaceuticals, Lilly, Materia Prima, Pfizer, Prometheus Biosciences, Reistone, Takeda, and Techlab Inc. CT, FA, AS, TGR have no relevant disclosures.
: This study was approved by the Institutional Review Board at the University of Chicago (IRB20-1979).
: Informed consent was obtained from all individual participants included in the study.
